Skip to main content
. 2020 Oct 26;10:536842. doi: 10.3389/fonc.2020.536842

Table 2.

Intraoperative and Postoperative characteristics of the two groups.

Surgical approaches (%) P-value
Right (N = 202) Left (N = 235)
Intraoperative Data
Median operative time (min) 250 190 <0.001*
Mean operative time (SD) (min) 293.02 (314.94) 201.77 (48.76) <0.001*
Mean blood loss (SD) (mL) 236.61 (239.18) 220.54 (189.23) 0.708
Median lymph nodes retrieved (range) N 25 (8–60) 21 (8–54) 0.002*
R1/R2 resection N (%) 2(1.04) 0 0.238
Level of anastomosis N (%) 0.800
Cervical 201 (100) 221 (96.09)
Thoracic 0 (0) 9 (3.91)
Anastomosis method N (%) 0.001*
Manual anastomosis 85 (42.08) 123 (52.34)
Mechanical anastomosis 105 (51.98) 111 (47.23)
Semi-mechanical anastomosis 12 (5.94) 1 (0.43)
Postoperative data
Median postoperative hospital stay days (range) 17 (7–68) 14 (4–75) <0.001*
Median mediastinal tube drainage days (range) 7 (3–34) 7 (3–28) 0.175
Myocardial arrhythmia N (%) 20 (9.90) 35 (14.89) 0.117
Pneumonia N (%) 34 (16.83) 26 (11.06) 0.081
Anastomotic leakage N (%) 4 (1.98) 5 (2.13) >0.999
In hospital mortality/90-days mortality N (%) 0 0 NA
Pathological data
pT stage T (%) 0.950
T1b 9 (4.46) 23 (9.79)
T2 56 (27.72) 46 (19.57)
T3 112 (55.45) 138 (58.72)
T4 25 (12.38) 28 (11.91)
pN stage N (%) 0.546
N0 111 (54.95) 143 (60.85)
N1 56 (27.72) 61 (25.96)
N2 27 (13.37) 25 (10.64)
N3 8 (3.96) 6 (2.55)
pTNM staging 7th N (%) 0.398
IA 6 (3.02) 11 (4.85)
IB 33 (16.58) 43 (18.94)
IIA 31 (15.58) 28 (12.33)
IIB 40 (20.10) 52 (22.91)
IIIA 40 (20.10) 43 (18.94)
IIIB 17 (8.54) 17 (7.49)
IIIC 32 (16.08) 33 (14.54)

MIE, minimally invasive esophagectomy; OE, open esophagectomy; N, number; SD, standard deviation; NA, Not Available; pN, pathological lymph nodes; pTNM, tumor/node/metastasis.

*

Statistically significant (p < 0.05).